fda removing semaglutide On February 21, 2025, the announced that semaglutide, the active ingredient in Ozempic and Wegovy, is no longer considered in shortage, signaling an improvement in national supply. As a result, compounding FDA moves to remove GLP-1

If a prescription is issued, your medication will be sent to you in discreet packaging

As we explore the potential benefits of these two powerful compounds, its essential to understand how they interact and whether taking them together is advisable

The question isn't whether oral GLP-1 therapy will reach the mass market

Hydration can help with constipation, headaches and tiredness

Increased Dehydration Risk Some patients experience nausea while taking Wegovy, Ozempic, or Mounjaro , and no one wants to guzzle water when they feel queasy

NAION occurs in up to about 10 out of every 100,000 people over age 50, according to the American Academy of Ophthalmology